Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh

Abdur Razzaque Sarker, Marufa Sultana, Rashidul Alam Mahumud, Robert Van Der Meer, Alec Morton

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Diarrhoea is one of the world's leading killers of children, and globally, rotavirus is the most common cause of severe diarrhoea among under five children. In Bangladesh, rotavirus kills nearly 6,000 under five children in each year. To reduce the burden of childhood rotavirus diseases, universal rotavirus vaccination is recommended by World Health Organization. The objective of this study is to assess the cost-effectiveness of introducing universal childhood rotavirus vaccination with the newly developed ROTAVAC vaccine in national Expanded Programme of Immunization in Bangladesh. We developed a decision model to examine the potential impact of vaccination in Bangladesh and to examine the effect if the vaccination is applied in the nationwide immunization program schedule. Introduction of childhood universal rotavirus vaccination in Bangladesh scenario appears as highly cost-effective and would offer substantial future benefits for the young population if vaccinated today. The cost per DALY averted of introducing the rotavirus vaccine compared to status quo is approximately US$ 740.27 and US$ 728.67 per DALY averted from the health system and societal perspective respectively which is “very cost-effective” using GDP threshold level according to World Health Organization definition. The results of this analysis seek to contribute to an evidence-based recommendation about the introduction of universal rotavirus vaccination in national Expanded Programme of Immunization (EPI) in Bangladesh.
LanguageEnglish
Number of pages10
JournalHuman Vaccines & Immunotherapeutics
Early online date3 Nov 2017
DOIs
Publication statusPublished - 12 Dec 2017

Fingerprint

Bangladesh
Rotavirus
Cost-Benefit Analysis
Vaccination
Immunization Programs
Costs and Cost Analysis
Diarrhea
Rotavirus Vaccines
Immunization Schedule
Cost-effectiveness analysis
Childhood
Vaccines
Health
Immunization
Population

Keywords

  • Bangladesh
  • childhood
  • cost-effective
  • rotavirus
  • vaccination

Cite this

@article{20e8fd71e46d4ad7be3b7aa61bd5b2f0,
title = "Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh",
abstract = "Diarrhoea is one of the world's leading killers of children, and globally, rotavirus is the most common cause of severe diarrhoea among under five children. In Bangladesh, rotavirus kills nearly 6,000 under five children in each year. To reduce the burden of childhood rotavirus diseases, universal rotavirus vaccination is recommended by World Health Organization. The objective of this study is to assess the cost-effectiveness of introducing universal childhood rotavirus vaccination with the newly developed ROTAVAC vaccine in national Expanded Programme of Immunization in Bangladesh. We developed a decision model to examine the potential impact of vaccination in Bangladesh and to examine the effect if the vaccination is applied in the nationwide immunization program schedule. Introduction of childhood universal rotavirus vaccination in Bangladesh scenario appears as highly cost-effective and would offer substantial future benefits for the young population if vaccinated today. The cost per DALY averted of introducing the rotavirus vaccine compared to status quo is approximately US$ 740.27 and US$ 728.67 per DALY averted from the health system and societal perspective respectively which is “very cost-effective” using GDP threshold level according to World Health Organization definition. The results of this analysis seek to contribute to an evidence-based recommendation about the introduction of universal rotavirus vaccination in national Expanded Programme of Immunization (EPI) in Bangladesh.",
keywords = "Bangladesh, childhood, cost-effective, rotavirus, vaccination",
author = "Sarker, {Abdur Razzaque} and Marufa Sultana and Mahumud, {Rashidul Alam} and {Van Der Meer}, Robert and Alec Morton",
note = "This is an Accepted Manuscript of an article published by Taylor & Francis in Human Vaccines & Immunotherapeutics on 03/11/2017, available online: https://doi.org/10.1080/21645515.2017.1356962",
year = "2017",
month = "12",
day = "12",
doi = "10.1080/21645515.2017.1356962",
language = "English",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",

}

Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh. / Sarker, Abdur Razzaque; Sultana, Marufa; Mahumud, Rashidul Alam; Van Der Meer, Robert; Morton, Alec.

In: Human Vaccines & Immunotherapeutics, 12.12.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh

AU - Sarker, Abdur Razzaque

AU - Sultana, Marufa

AU - Mahumud, Rashidul Alam

AU - Van Der Meer, Robert

AU - Morton, Alec

N1 - This is an Accepted Manuscript of an article published by Taylor & Francis in Human Vaccines & Immunotherapeutics on 03/11/2017, available online: https://doi.org/10.1080/21645515.2017.1356962

PY - 2017/12/12

Y1 - 2017/12/12

N2 - Diarrhoea is one of the world's leading killers of children, and globally, rotavirus is the most common cause of severe diarrhoea among under five children. In Bangladesh, rotavirus kills nearly 6,000 under five children in each year. To reduce the burden of childhood rotavirus diseases, universal rotavirus vaccination is recommended by World Health Organization. The objective of this study is to assess the cost-effectiveness of introducing universal childhood rotavirus vaccination with the newly developed ROTAVAC vaccine in national Expanded Programme of Immunization in Bangladesh. We developed a decision model to examine the potential impact of vaccination in Bangladesh and to examine the effect if the vaccination is applied in the nationwide immunization program schedule. Introduction of childhood universal rotavirus vaccination in Bangladesh scenario appears as highly cost-effective and would offer substantial future benefits for the young population if vaccinated today. The cost per DALY averted of introducing the rotavirus vaccine compared to status quo is approximately US$ 740.27 and US$ 728.67 per DALY averted from the health system and societal perspective respectively which is “very cost-effective” using GDP threshold level according to World Health Organization definition. The results of this analysis seek to contribute to an evidence-based recommendation about the introduction of universal rotavirus vaccination in national Expanded Programme of Immunization (EPI) in Bangladesh.

AB - Diarrhoea is one of the world's leading killers of children, and globally, rotavirus is the most common cause of severe diarrhoea among under five children. In Bangladesh, rotavirus kills nearly 6,000 under five children in each year. To reduce the burden of childhood rotavirus diseases, universal rotavirus vaccination is recommended by World Health Organization. The objective of this study is to assess the cost-effectiveness of introducing universal childhood rotavirus vaccination with the newly developed ROTAVAC vaccine in national Expanded Programme of Immunization in Bangladesh. We developed a decision model to examine the potential impact of vaccination in Bangladesh and to examine the effect if the vaccination is applied in the nationwide immunization program schedule. Introduction of childhood universal rotavirus vaccination in Bangladesh scenario appears as highly cost-effective and would offer substantial future benefits for the young population if vaccinated today. The cost per DALY averted of introducing the rotavirus vaccine compared to status quo is approximately US$ 740.27 and US$ 728.67 per DALY averted from the health system and societal perspective respectively which is “very cost-effective” using GDP threshold level according to World Health Organization definition. The results of this analysis seek to contribute to an evidence-based recommendation about the introduction of universal rotavirus vaccination in national Expanded Programme of Immunization (EPI) in Bangladesh.

KW - Bangladesh

KW - childhood

KW - cost-effective

KW - rotavirus

KW - vaccination

UR - http://www.tandfonline.com/toc/khvi20/current

U2 - 10.1080/21645515.2017.1356962

DO - 10.1080/21645515.2017.1356962

M3 - Article

JO - Human Vaccines and Immunotherapeutics

T2 - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

ER -